##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 97 Download : 47

##plugins.themes.academic_pro.article.main##

Abstract

Arterial hypertension, a significant risk factor for cardiovascular illnesses, has posed intricate management issues, especially in patients following COVID-19. Recent evidence indicates that COVID-19's effects on cardiovascular health may modify traditional hypertension therapy protocols. Recent studies reveal that post-COVID-19 patients frequently experience increased cardiovascular strain, which may be mitigated with non-pharmacological therapies. Investigating non-pharmacological strategies, such as lifestyle alterations encompassing physical activity, nutrition, and stress reduction, may offer alternative means to maintain blood pressure without dependence on medication. This retrospective study evaluates the effectiveness of these ways in managing arterial hypertension in post-COVID-19 patients, with the objective of identifying feasible strategies for preserving cardiovascular health and comprehending the wider implications of COVID-19 on hypertensive disorders.

Keywords

Arterial Hypertension Non-Pharmacological Treatment Post-COVID-19 Management

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Khaidarov J. G, & Tolibjonov D. T. (2024). Treatment Of Arterial Hypertension Without Medication After Covid-19 Infection. Texas Journal of Multidisciplinary Studies, 39, 1–6. https://doi.org/10.62480/tjms.2024.vol39.5740.pp1-6

References

  1. J. Wu et al., "COVID-19 and cardiovascular complications: A focus on hypertensive patients and risk of
  2. hypertension post-COVID-19," J. Hypertens., vol. 39, no. 5, pp. 1045–1052, 2021.
  3. M. N. Kumari and K. J. Verma, "Impact of COVID-19 on endothelial function and its implications for
  4. hypertension," Int. J. Cardiovasc. Res., vol. 12, no. 3, pp. 234–241, 2021.
  5. R. Sanchez-Gomez, A. Olivares, and S. Torres, "Long-term cardiovascular implications of COVID-19:
  6. Analysis of lifestyle, stress, and vascular health," Am. J. Cardiovasc. Dis., vol. 11, no. 2, pp. 178–186, 2022.
  7. C. Zhao, Y. Liu, and P. Zhang, "Exploring non-pharmacological strategies for managing hypertension in
  8. a post-COVID-19 context," Hypertens. J., vol. 14, no. 1, pp. 65–73, 2022.
  9. L. D. Yadav and M. Srivastava, "Efficacy of lifestyle interventions in managing blood pressure: Insights
  10. for post-COVID-19 care," Clin. Hypertens., vol. 28, no. 4, pp. 93–100, 2021.
  11. A. Ali et al., "Impact of exercise on blood pressure among post-COVID-19 patients: A longitudinal
  12. study," J. Cardiovasc. Health, vol. 10, no. 3, pp. 205–213, 2022.
  13. J. Lopez et al., "Dietary modifications for hypertension management in post-COVID-19 patients," Nutr.
  14. Health, vol. 9, no. 2, pp. 133–140, 2022.
  15. R. Gupta et al., "DASH diet in hypertension management post-COVID-19 infection," J. Nutr. Med., vol.
  16. , no. 1, pp. 45–54, 2023.
  17. D. Jones and F. Smith, "Mindfulness-based stress reduction for hypertension in COVID-19 survivors," J.
  18. Clin. Hypertens., vol. 15, no. 2, pp. 98–109, 2022.
  19. L. Tan et al., "Yoga as a non-pharmacological intervention for hypertension in post-COVID patients,"
  20. Health Psychol., vol. 13, no. 1, pp. 71–83, 2023.
  21. M. Lin and Y. Zhang, "Role of hydration in blood pressure control post-COVID-19," Int. J. Cardiovasc.
  22. Res., vol. 14, no. 3, pp. 187–192, 2022.
  23. F. Wang et al., "Impact of salt intake reduction on blood pressure in post-COVID-19 patients,"
  24. Hypertens. Res., vol. 17, no. 4, pp. 291–301, 2022.
  25. C. Brown and A. Patel, "Sleep hygiene and hypertension in post-COVID-19 cases," Sleep Health, vol.
  26. , no. 3, pp. 112–118, 2022.
  27. Y. Lee and J. Garcia, "Mental health support as an adjunct for hypertension management post-COVID19," Am. J. Public Health, vol. 7, no. 2, pp. 99–110, 2023.
  28. Z. Zhao et al., "Challenges of non-pharmacological hypertension management post-COVID-19," J.
  29. Health Socioecon., vol. 4, no. 1, pp. 45–59, 2023.